These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37657524)

  • 41. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
    Skulas-Ray AC; West SG; Davidson MH; Kris-Etherton PM
    Expert Opin Pharmacother; 2008 May; 9(7):1237-48. PubMed ID: 18422480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fish oil for the treatment of cardiovascular disease.
    Weitz D; Weintraub H; Fisher E; Schwartzbard AZ
    Cardiol Rev; 2010; 18(5):258-63. PubMed ID: 20699674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omega-3 fatty acids from fish oils and cardiovascular disease.
    Holub DJ; Holub BJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fish consumption and cardiovascular disease related biomarkers: A review of clinical trials.
    Petsini F; Fragopoulou E; Antonopoulou S
    Crit Rev Food Sci Nutr; 2019; 59(13):2061-2071. PubMed ID: 29420061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of omega-3 fatty acids in hypertriglyceridemic states.
    Connor WE
    Semin Thromb Hemost; 1988 Jul; 14(3):271-84. PubMed ID: 3051392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Omega-3 fatty acids, fish, fish oil and cardiovascular disease--a review with implications to Israeli nutritional guidelines].
    Eilat-Adar S; Lipovetzky N; Goldbourt U; Henkin Y
    Harefuah; 2004 Aug; 143(8):585-91, 622, 621. PubMed ID: 15523812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of short-term use of omega-3-type polyunsaturated fatty acids in subjects with hypertriglyceridemia].
    Naber FB; Oudkerk Pool M; Teerlink T; Popp-Snijders C; Gans RO; Bilo HJ
    Ned Tijdschr Geneeskd; 1992 Aug; 136(31):1511-4. PubMed ID: 1495569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.
    Quispe R; Alfaddagh A; Kazzi B; Zghyer F; Marvel FA; Blumenthal RS; Sharma G; Martin SS
    Curr Atheroscler Rep; 2022 Jul; 24(7):571-581. PubMed ID: 35499805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia.
    Backes J; Anzalone D; Hilleman D; Catini J
    Lipids Health Dis; 2016 Jul; 15(1):118. PubMed ID: 27444154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fish Oil Dilemma: Does It Increase the Risk of Ventricular Arrhythmias and Death? Can Fish Oil Kill You?
    Asfaw A; Minhas S; Khouzam AR; Khouzam NR; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100718. PubMed ID: 33097299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does coconut oil improve cholesterol by raising good cholesterol, or should I use fish oil?
    Mayo Clin Health Lett; 2012 Aug; 30(8):8. PubMed ID: 23045741
    [No Abstract]   [Full Text] [Related]  

  • 52. Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia.
    Tatsuno I
    Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1261-8. PubMed ID: 25319059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
    Nicholls SJ; Lincoff AM; Garcia M; Bash D; Ballantyne CM; Barter PJ; Davidson MH; Kastelein JJP; Koenig W; McGuire DK; Mozaffarian D; Ridker PM; Ray KK; Katona BG; Himmelmann A; Loss LE; Rensfeldt M; Lundström T; Agrawal R; Menon V; Wolski K; Nissen SE
    JAMA; 2020 Dec; 324(22):2268-2280. PubMed ID: 33190147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dietary echium oil increases long-chain n-3 PUFAs, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome.
    Kuhnt K; Fuhrmann C; Köhler M; Kiehntopf M; Jahreis G
    J Nutr; 2014 Apr; 144(4):447-60. PubMed ID: 24553695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
    Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
    J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
    Scherer DJ; Nicholls SJ
    Vasc Health Risk Manag; 2015; 11():203-9. PubMed ID: 25848301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health.
    Djuricic I; Calder PC
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():383-406. PubMed ID: 36662586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological control of hypertriglyceridemia.
    Franceschini G; Paoletti R
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):297-302. PubMed ID: 8364001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?
    Kromhout D; Yasuda S; Geleijnse JM; Shimokawa H
    Eur Heart J; 2012 Feb; 33(4):436-43. PubMed ID: 21933782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.